{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:11:33Z","timestamp":1784693493896,"version":"3.55.0"},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T00:00:00Z","timestamp":1431475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Otolaryngology"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Incidence rates of <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>eniere's syndrome\/disease vary considerably from 157 per 100\u00a0000 in the <jats:styled-content style=\"fixed-case\">U<\/jats:styled-content>nited <jats:styled-content style=\"fixed-case\">K<\/jats:styled-content>ingdom to 15 per 100\u00a0000 in the <jats:styled-content style=\"fixed-case\">U<\/jats:styled-content>nited <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>tates. A wide range of treatments are used for the treatment of the condition with no consensus on the most effective intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To assess the effectiveness of the <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>eniett device in reducing the frequency and severity of vertigo in <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>eniere's syndrome\/disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Search methods<\/jats:title><jats:p>The <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>ochrane <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>ar, <jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>ose and <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>hroat <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>isorders <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>roup <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>rials <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>egister; the <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>ochrane <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>entral <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>egister of <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>ontrolled <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>rials (<jats:styled-content style=\"fixed-case\">CENTRAL<\/jats:styled-content>); <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>ub<jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>ed; <jats:styled-content style=\"fixed-case\">EMBASE<\/jats:styled-content>;<jats:styled-content style=\"fixed-case\"> CINAHL<\/jats:styled-content>;<jats:styled-content style=\"fixed-case\"> W<\/jats:styled-content>eb of <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>cience; <jats:styled-content style=\"fixed-case\">BIOSIS P<\/jats:styled-content>reviews; <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>ambridge <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>cientific abstracts; <jats:styled-content style=\"fixed-case\">ICTRP<\/jats:styled-content> and additional sources for published and unpublished trials were searched. The date of the last search was 13th <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>ay 2014.<\/jats:p><\/jats:sec><jats:sec><jats:title>Selection criteria<\/jats:title><jats:p>Four randomised controlled trials (<jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>s) were identified that compared the efficacy of the <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>eniett device versus a placebo device in patients with <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>eniere's \u2018disease\u2019 as defined by the <jats:styled-content style=\"fixed-case\">AAOO<\/jats:styled-content> criterion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data collection and analysis<\/jats:title><jats:p>Two review authors independently assessed study eligibility and risk of bias and extracted data. The outcome data were dichotomous for all the included trials.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main results<\/jats:title><jats:p>The four <jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>s compared 123 patients with the <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>eniett device against 114 patients with the placebo device from four <jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>'s over a follow\u2010up period of 2\u00a0weeks to 4\u00a0months. There was a significant overall 61% reduction in the frequency of vertigo in both groups (mean no vertigo days per month of 8\u20133). However, this reduction was not significantly different between the two groups in any study or on meta\u2010analysis [mean difference in vertigo\u2010free days between <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>eniett and placebo device of 0.77\u00a0days over a 1\u2010month period (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> \u2013 0.82, 1.83) <jats:italic>P<\/jats:italic>\u00a0=\u00a00.45].<\/jats:p><jats:p>There were also no substantive data to support a greater reduction in the severity of the vertigo or any other outcome with the <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>eniett device compared with the placebo device.<\/jats:p><\/jats:sec><jats:sec><jats:title>Authors conclusions<\/jats:title><jats:p>No evidence was found to justify the use of the <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>eniett device in <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>eniere's syndrome\/disease.<\/jats:p><\/jats:sec>","DOI":"10.1111\/coa.12344","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T05:48:14Z","timestamp":1414129694000},"page":"197-207","source":"Crossref","is-referenced-by-count":19,"title":["Positive pressure therapy for <scp>M<\/scp>eniere's syndrome\/disease with a <scp>M<\/scp>eniett device: a systematic review of randomised controlled trials"],"prefix":"10.1111","volume":"40","author":[{"given":"M.I.","family":"Syed","sequence":"first","affiliation":[{"name":"Department of Otolaryngology The Royal Infirmary Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Rutka","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology University of Toronto University Health Network Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hendry","sequence":"additional","affiliation":[{"name":"Department of Surgery Glasgow Royal Infirmary Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.G.","family":"Browning","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology MRC\/CSO Institute of Hearing Research Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,13]]},"reference":[{"key":"e_1_2_10_2_1","first-page":"29","article-title":"Sur une forme de surdit\u00e9 grave d\u00e9pendant d'une l\u00e9sionde l'oreille interne","volume":"16","author":"M\u00e9ni\u00e8re P.","year":"1861","journal-title":"Gaz. M\u00e9d. (Paris)"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200402000-00004"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200501000-00013"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(95)70102-8"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2010.05.005"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003599.pub2"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001873"},{"key":"e_1_2_10_9_1","first-page":"CD008514","article-title":"Intratympanic steroids for M\u00e9ni\u00e8re's disease or syndrome","volume":"7","author":"Phillips J.S.","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_10_10_1","first-page":"CD008234","article-title":"Intratympanic gentamicin for M\u00e9ni\u00e8re's disease or syndrome","volume":"3","author":"Pullens B.","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_10_11_1","first-page":"CD005395","article-title":"Surgery for M\u00e9ni\u00e8re's disease","volume":"2","author":"Pullens B.","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/000164800750044461"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348948409300106"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016488809125063"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1008888"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2005.01.012"},{"key":"e_1_2_10_17_1","first-page":"253","article-title":"Diazepam as an anti\u2010motion sickness drug","volume":"11","author":"McClure J.A.","year":"1982","journal-title":"J. Otolaryngol."},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000276915"},{"key":"e_1_2_10_19_1","first-page":"1","article-title":"Direct measurement of the flow resistance of the cochlear aqueduct in the guinea pig","volume":"124","author":"Thalen E.O.","year":"2004","journal-title":"Acta Otolaryngol."},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/00016480510012237"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200501000-00012"},{"key":"e_1_2_10_22_1","volume-title":"Cochrane Hand Book for Systematic Reviews of Interventions 5.1.0 [updated March 2011]","author":"Higgins J.P.T.","year":"2011"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.130.6.718"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/000164800454107"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215112000102"},{"key":"e_1_2_10_26_1","first-page":"726","article-title":"Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Meni\u00e8re's disease: a clinical placebo\u2010controlled study","volume":"18","author":"Densert B.","year":"1997","journal-title":"Am. J. Otol."},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c869"}],"container-title":["Clinical Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcoa.12344","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/coa.12344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T07:33:01Z","timestamp":1758526381000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/coa.12344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,13]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1111\/coa.12344"],"URL":"https:\/\/doi.org\/10.1111\/coa.12344","archive":["Portico"],"relation":{},"ISSN":["1749-4478","1749-4486"],"issn-type":[{"value":"1749-4478","type":"print"},{"value":"1749-4486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,13]]}}}